BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stino AM, Rumora AE, Kim B, Feldman EL. Evolving concepts on the role of dyslipidemia, bioenergetics, and inflammation in the pathogenesis and treatment of diabetic peripheral neuropathy. J Peripher Nerv Syst. 2020;25:76-84. [PMID: 32412144 DOI: 10.1111/jns.12387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Silva-Alves KS, Ferreira-da-Silva FW, Coelho-de-Souza AN, Leal-Cardoso JH. Essential Oil of Croton zehntneri Prevents Conduction Alterations Produced by Diabetes Mellitus on Vagus Nerve. Plants (Basel) 2021;10:893. [PMID: 33925228 DOI: 10.3390/plants10050893] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mizukami H, Osonoi S. Pathogenesis and Molecular Treatment Strategies of Diabetic Neuropathy Collateral Glucose-Utilizing Pathways in Diabetic Polyneuropathy. Int J Mol Sci. 2020;22. [PMID: 33374137 DOI: 10.3390/ijms22010094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 Schlereth T, Morellini N, Lismont NCAM, Lemper C, Birklein F, Drummond PD. Alpha 1 adrenoceptor expression in skin, nerves and blood vessels of patients with painful diabetic neuropathy. Auton Neurosci 2021;234:102814. [PMID: 33964567 DOI: 10.1016/j.autneu.2021.102814] [Reference Citation Analysis]
4 Chiang JCB, Arnold R, Dhanapalaratnam R, Markoulli M, Krishnan AV. Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders. Pharmaceuticals 2022;15:607. [DOI: 10.3390/ph15050607] [Reference Citation Analysis]
5 Bonomo R, Kramer S, Aubert V. Obesity-Associated Neuropathy: Recent Preclinical Studies and Proposed Mechanisms. Antioxidants & Redox Signaling. [DOI: 10.1089/ars.2021.0278] [Reference Citation Analysis]
6 Hossain MJ, Kendig MD, Wild BM, Issar T, Krishnan AV, Morris MJ, Arnold R. Evidence of Altered Peripheral Nerve Function in a Rodent Model of Diet-Induced Prediabetes. Biomedicines 2020;8:E313. [PMID: 32872256 DOI: 10.3390/biomedicines8090313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Allam MA, Nassar YA, Shabana HS, Mostafa S, Khalil F, Zidan H, Abo-Ghebsha M, Abdelghaffar A, Essmat A, Elmahdi E. Prevalence and Clinical Significance of Subclinical Hypothyroidism in Diabetic Peripheral Neuropathy. Int J Gen Med 2021;14:7755-61. [PMID: 34785933 DOI: 10.2147/IJGM.S337779] [Reference Citation Analysis]
8 Zhao Y, Xie L, Zhang H, Zhou S, Liu Y, Chen J, Wang L, Wang L, Zhuo L, Wang Y, Ou N, Shao F. Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of SY-004, a Glucokinase Activator, in Healthy Chinese Adults: A Randomized, Phase Ia, Single-Ascending Dose Study. Clinical Therapeutics 2022. [DOI: 10.1016/j.clinthera.2021.12.009] [Reference Citation Analysis]
9 Guan H, Ye M, Fang C, Zhang L, Han P, Qiu S, Fang X, Li L. The clinical effectiveness and safety of alprostadil combined with alpha lipoic acid in the treatment of diabetic peripheral neuropathy: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e23507. [PMID: 33327292 DOI: 10.1097/MD.0000000000023507] [Reference Citation Analysis]
10 Rajbhandari J, Fernandez CJ, Agarwal M, Yeap BXY, Pappachan JM. Diabetic heart disease: A clinical update. World J Diabetes 2021;12:383-406. [PMID: 33889286 DOI: 10.4239/wjd.v12.i4.383] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
11 Jankovic M, Novakovic I, Nikolic D, Mitrovic Maksic J, Brankovic S, Petronic I, Cirovic D, Ducic S, Grajic M, Bogicevic D. Genetic and Epigenomic Modifiers of Diabetic Neuropathy. Int J Mol Sci 2021;22:4887. [PMID: 34063061 DOI: 10.3390/ijms22094887] [Reference Citation Analysis]
12 Yuan Q, Zhang X, Wei W, Zhao J, Wu Y, Zhao S, Zhu L, Wang P, Hao J. Lycorine improves peripheral nerve function by promoting Schwann cell autophagy via AMPK pathway activation and MMP9 downregulation in diabetic peripheral neuropathy. Pharmacol Res 2021;175:105985. [PMID: 34863821 DOI: 10.1016/j.phrs.2021.105985] [Reference Citation Analysis]
13 Hagen KM, Ousman SS. Aging and the immune response in diabetic peripheral neuropathy. J Neuroimmunol 2021;355:577574. [PMID: 33894676 DOI: 10.1016/j.jneuroim.2021.577574] [Reference Citation Analysis]
14 Zhao B, Zhang Q, Liang X, Xie J, Sun Q. Quercetin reduces inflammation in a rat model of diabetic peripheral neuropathy by regulating the TLR4/MyD88/NF-κB signalling pathway. Eur J Pharmacol 2021;912:174607. [PMID: 34743981 DOI: 10.1016/j.ejphar.2021.174607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Cernea S, Raz I. Management of diabetic neuropathy. Metabolism 2021;123:154867. [PMID: 34411554 DOI: 10.1016/j.metabol.2021.154867] [Reference Citation Analysis]